首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients
【24h】

Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients

机译:老龄化,长期阿片类药物维持治疗患者的大和非特异性躯体疾病负担

获取原文
           

摘要

To describe and explore somatic disease burdens of ageing long-term patients in opioid maintenance treatment (OMT), a unique population emerging in countries offering OMT as a?long-term treatment. We used data from the Norwegian Cohort of Patient in Opioid Maintenance Treatment and Other Drug Treatment Study (NorComt). 156 patients enrolled for at least three of the past five years provided data during structured interviews, including on chronic conditions, somatic treatment received, mental distress (SCL-25), and treatment satisfaction. A somatic disease burden was calculated from a list measuring the recent severity of 16 somatic complaints. A hierarchical multiple linear regression analysis identified correlates of somatic disease burden. Over half of patients reported at least seven somatic complaints. Reported somatic disease burden was associated with higher mental distress, more chronic conditions, fewer years in OMT, and treatment dissatisfaction. Age was unrelated, and there were few gender differences. These five variables explained 43.6% of the variance in disease burden. Long-term OMT patients experience a large range of somatic complaints, and at non-acute levels. As OMT secures longevity for opioid-dependent persons, the clinical focus must be adjusted from acute to chronic care. Providers must address how to optimize health and quality of life while in treatment, as treatment may last for many years.
机译:描述和探索躯体疾病的龄在阿片类药物维持治疗(OMT)中的老龄化患者,在提供OMT的各国中出现的独特人群作为一个人的长期治疗。我们使用来自阿片类药物维持治疗和其他药物治疗研究(NORCOMT)的挪威患者患者群体的数据。 156例患者在过去五年中至少有三个患者提供了结构性访谈期间的数据,包括慢性病,治疗细胞疗法,精神痛苦(SCL-25)和治疗满意度。从列表中衡量最近16个躯体投诉的最严重程度的列表计算了躯体疾病负担。分层多线性回归分析确定了躯体疾病负担的相关性。超过一半的患者报告了至少七个躯体抱怨。报道的躯体疾病负担与较高的精神痛苦,更长期的病症,众多慢性病以及治疗不满。年龄不相关,性别差异很少。这五个变量解释了疾病负担差异的43.6%。长期OMT患者体验了大量的体细胞投诉,并且在非急性水平。随着OMT为阿片类药物依赖的人确保寿命,临床焦点必须从急性到慢性护理调整。提供商必须解决如何优化治疗时的健康和生活质量,因为治疗可能持续多年。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号